摘要:
The present invention provides an extremely useful and novel β-galactoside-α2,6-sialyltransferase having an optimum reaction pH in a neutral to alkaline range, and a nucleic acid encoding the sialyltransferase. The present invention further provides a vector carrying a nucleic acid encoding the sialyltransferase, and a host cell transformed with the vector, as well as a method for producing a recombinant β-galactoside-α2,6-sialyltransferase.
摘要:
The present invention provides an extremely useful and novel β-galactoside-α2,6-sialyltransferase having an optimum reaction pH in a neutral to alkaline range, and a nucleic acid encoding the sialyltransferase. The present invention further provides a vector carrying a nucleic acid encoding the sialyltransferase, and a host cell transformed with the vector, as well as a method for producing a recombinant β-galactoside-α2,6-sialyltransferase.
摘要:
The present invention provides an extremely useful and novel β-galactoside-α2,6-sialyltransferase having an optimum reaction pH in a neutral to alkaline range, and a nucleic acid encoding the sialyltransferase. The present invention further provides a vector carrying a nucleic acid encoding the sialyltransferase, and a host cell transformed with the vector, as well as a method for producing a recombinant β-galactoside-α2,6-sialyltransferase.
摘要:
The present invention provides a novel method that can increase readily a virus or viral vector concentration in a solution having a low concentration and a kit for performing the method. Conventional methods require complicated operations, expensive equipment, or highly trained experts for efficiently concentrating viruses from low-concentration virus solutions. The method of the present invention can concentrate viral vectors readily while maintaining infection abilities of the viral vectors, and thus it can be used as a safe and simple technique for concentrating a vector useful in the field of a genetic therapy or a vaccine therapy using a viral vector.
摘要:
The present invention relates to a method of quantitatively determining the number of human herpesvirus (HHV) collected from a body fluid and a kit for performing the method. Conventionally, a trained technician has been required to accurately quantitatively determine a number of HHV collected from a body fluid. The method of the present invention is a novel method of quantitative determination that enables measurement of a number of HHV in a body fluid to be simply, accurately, and efficiently determined. The method of the present invention can enable continuous evaluation of the number of HHV in body fluids and, therefore, can be applied to quantitative evaluation of the accumulation of fatigue.
摘要:
For use in deciding optimum pole and zero parameters for an input signal with reference to an input cepstrum of the signal, candidate pole and zero parameters are stored in advance in a table. Supplied with an impulse and controlled by a candidate set pair of a pole parameter set and a zero parameter set selected from the candidate pole and zero parameters of the table, first and second filters produce first and second outputs defined by terms of up to a certain order. Responsive to the first and second outputs and to factors of multiplication which are given by inverse numbers of time intervals related to the respective terms, an analysis filter produces a converted signal which is equivalent to a model output cepstrum of a model output signal produced by a pole-zero model defined by the candidate set pair. A cepstrum subtracter calculates a cepstrum difference between the input cepstrum and the converted signal. In connection with a few candidate set pairs, cepstrum differences and then squares of the respective cepstrum differences are calculated to decide the optimum pole and zero parameters by a focussing technique. Alternatively, a square of the cepstrum difference is used together with partial derivatives of the square to decide the optimum pole and zero parameters.
摘要:
The present invention relates to a modified biotin-binding protein. The modified biotin-binding protein of the present invention includes an amino acid sequence represented by SEQ ID NO: 2, an amino acid sequence having one to several amino acid mutations in the sequence represented by SEQ ID NO: 2, or an amino acid sequence having 80% or more identity to the sequence represented by SEQ ID NO: 2, and having a biotin-binding activity, wherein at least one residue selected from the group consisting of: 1) an arginine residue at position 104 of SEQ ID NO: 2; 2) a lysine residue at position 141 of SEQ ID NO: 2; 3) a lysine residue at position 26 of SEQ ID NO: 2; and 4) a lysine residue at position 73 of SEQ ID NO: 2 is replaced with an acidic amino acid residue or a neutral amino acid residue.
摘要翻译:本发明涉及修饰的生物素结合蛋白。 本发明的修饰的生物素结合蛋白包括SEQ ID NO:2所示的氨基酸序列,在SEQ ID NO:2所示的序列中具有1〜数个氨基酸突变的氨基酸序列,或氨基酸序列 与SEQ ID NO:2表示的序列具有80%以上的同一性,并且具有生物素结合活性,其中至少一个选自以下的残基:1)SEQ ID NO:2的104位的精氨酸残基, 2; 2)SEQ ID NO:2的141位的赖氨酸残基; 3)SEQ ID NO:2的26位的赖氨酸残基; 和4)SEQ ID NO:2的第73位的赖氨酸残基被酸性氨基酸残基或中性氨基酸残基取代。
摘要:
The present invention relates to a solid support having a heat-resistant biotin-binding protein attached thereto. The present invention also relates to the use of the solid support of the present invention having a heat-resistant biotin-binding protein attached thereto. The present invention further relates to technical fields such as purification, concentration, detection and/or capture of a biotin-linked substance by means of a heat-resistant biotin-binding protein. Such a biotin-binding protein used in the solid support of the present invention is heat-resistant and is therefore useful for use in assay systems involving exposure to a temperature of 70° C. or more.
摘要:
The present invention provides an extremely useful and novel β-galactoside-α2,6-sialyltransferase having an optimum reaction pH in a neutral to alkaline range, and a nucleic acid encoding the sialyltransferase. The present invention further provides a vector carrying a nucleic acid encoding the sialyltransferase, and a host cell transformed with the vector, as well as a method for producing a recombinant β-galactoside-α2,6-sialyltransferase.
摘要:
The present invention provides a method of binding a protein to a carrier in such a way that the protein is not impaired in its function but can be allowed to act more efficiently than when it is bound directly.The method of the present invention for binding a protein to a carrier comprises: preparing a biotin-bound carrier; preparing a fusion protein having the protein bound to a tamavidin; and binding the protein to the carrier via tamavidin-biotin bonds.